High Tide Inc. (HITI:CA) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights strong financial performance, including record high revenue and free cash flow, improved margins, and strategic growth plans in Europe and the U.S. Despite some market slowdown concerns, management's optimistic guidance and strategic initiatives like store expansion and e-commerce improvements suggest a positive outlook. The Q&A section reveals some uncertainties, but overall, the sentiment is positive, with strategic partnerships and market expansion plans expected to drive growth. The lack of market cap information prevents further granularity, but the overall sentiment leans towards a positive stock price movement.
Key Financial Performance
Revenue $178.3 million, up 25% year-over-year, growing at its fastest pace in 10 quarters and up 9% sequentially. The increase is attributed to strong performance in both domestic and international segments.
Adjusted EBITDA $11.5 million, up 62% year-over-year, marking the fastest pace of growth in 2 years. This growth is driven by rising margins in the domestic core bricks-and-mortar segment and improved performance in international business.
Gross Margins (Consolidated) 25% in Q1, consistent with Q4 last year but slightly below 26% sequentially. The slight decline is due to lower gross margins in the medical cannabis distribution segment caused by supply chain delays in Portugal.
Gross Margins (Brick-and-Mortar Segment) 28%, marking the fifth straight quarter of sequential gains and the highest level in over 3 years. This improvement is attributed to higher-margin initiatives gaining traction.
Free Cash Flow $2.9 million, a significant improvement from negative $1.9 million in Q1 last year and more than double the $1.3 million generated in Q4. This improvement is driven by strong performance in the core Canadian bricks-and-mortar business.
Market Share (Canna Cabana) 12% in the 5 provinces where the company operates, up from 11% a year ago and 10% two years ago. This increase is attributed to the success of the loyalty-based discount club model.
Revenue (Remexian) $25 million in Q1, averaging over $8 million a month. February alone generated $12 million, a record since acquiring a majority stake. The growth is attributed to improved procurement strategies and increased market share in Germany.
Free Cash Flow (Trailing 12 Months) $16.8 million, the highest level in the past 5 quarters. This is attributed to the strong performance of the core Canadian bricks-and-mortar business and operational efficiencies.
Adjusted EBITDA Margin (Brick-and-Mortar Segment) 9% in Q1, consistent with Q4 and significantly higher than the 6% in Q1 last year. This improvement is due to higher-margin initiatives and operational efficiencies.
General and Administrative Expenses 4.1% of revenue in Q1, marking a 6-quarter low. This reduction is attributed to strong cost controls and operating leverage as revenue scales.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Revenue from new products: Revenue for the quarter was $178.3 million, up 25% year-over-year, growing at its fastest pace in 10 quarters and up 9% sequentially. Adjusted EBITDA was $11.5 million, up 62% year-over-year, marking the fastest pace of growth in 2 years.
International business growth: The newer international business, particularly in Germany, is picking up steam. Remexian's revenue was $25 million in Q1, averaging over $8 million a month. February alone saw $12 million in revenue from 2.6 tonnes of medical cannabis sold.
Market share growth: Canna Cabana's market share in the 5 provinces where it operates increased to 12% during November and December, up from 11% a year ago and 10% two years ago.
Expansion in Germany: Remexian increased its market share of German imports from 6.5% to 10.3% for the 3 months ending December 2025. Plans to expand into the U.K. within the next 12 months were also mentioned.
Operational efficiencies: General and administrative expenses represented just 4.1% of revenue, marking a 6-quarter low. Salaries and wages also showed improvement, representing 11.8% of revenue compared to 12.3% a year ago.
Free cash flow generation: High Tide generated $2.9 million in free cash flow in Q1, a significant improvement from negative $1.9 million in Q1 last year. Over the past 12 months, $16.8 million in free cash flow was generated, the highest in 5 quarters.
Loyalty program growth: Canna Cabana's loyalty program reached 2.58 million members in Canada, up 47% year-over-year. ELITE membership grew 100% year-over-year to 162,000 members.
Future expansion plans: Plans to add 20-30 stores in Canada during the calendar year, aiming to exceed 350 stores. Exploring opportunities to expand the Canna Cabana brand into the U.S. through licensing agreements.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Supply Chain Delays in Portugal: The company faced supply chain delays in Portugal, which impacted the gross margins of its medical cannabis distribution segment. This issue is expected to improve as fresh biomass from Canada starts arriving in Germany.
Working Capital Investments for Remexian: Growing the Remexian business requires significant working capital investments, especially with inventory stalled in Portugal and deposits for new biomass from Canada.
New Store Ramp-Up Challenges: The ramp-up of new stores is slower due to increased competition and a broader slowdown in industry growth rates, which acts as a drag on financial performance.
Potential Regulatory Headwinds in Germany: There could be headwinds in Germany regarding a new law governing medical cannabis access, although the company is optimistic about the outcome.
Economic and Competitive Pressures in Retail: Despite strong performance, the company acknowledges increased competition and a slowdown in broader industry growth rates, which could impact new store performance and overall market share.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: The company anticipates sustained revenue growth, with a target to exceed $700 million in annual revenue run rate. The international business, particularly in Germany, is expected to contribute significantly to this growth.
Store Expansion: High Tide plans to add 20 to 30 new stores in Canada during the calendar year, aiming to exceed 350 stores nationwide in the long term. Most of this expansion will be organic, with potential supplemental M&A opportunities.
White Label Products: The company aims to increase the contribution of higher-margin white label products to approximately 20% of total sales over the long term, up from the current 1.6%.
German Market Expansion: Remexian, the company's German subsidiary, is expected to see improved profitability as Canadian biomass imports begin arriving. The company is also exploring opportunities to expand into other international markets, including the U.K., within the next 12 months.
U.S. CBD Market: High Tide is optimistic about the potential for its U.S. CBD e-commerce business, particularly with the possibility of CBD pilot projects through Medicare. The company is also exploring licensing agreements to bring its Canna Cabana brand to the U.S.
Operational Efficiency: The company expects continued improvements in gross margins, particularly in its core brick-and-mortar segment, and aims to maintain strong cost controls to enhance profitability.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What was the impact of winter storms on same-store sales in Canada, and how is the metric trending quarter-to-date?
A:Winter storms, particularly in the last 10 days of January and into February, significantly impacted same-store sales in Canada. Despite this, same-store sales were up 2% year-over-year for the 3 months ending December 2025 and showed slight growth in January. The market is slowing, but the company believes it will continue to outperform due to its strong model and execution.
Q:What are the plans for entering the U.K. market, and how will it be funded?
A:The company plans to enter the U.K. market within the next 12 months. The U.K. market is growing rapidly, with projections of 60%-100% growth this year. Management is meeting with key players and is in no rush to enter, ensuring a strategic approach. Funding details were not explicitly provided, but the company is not cash-strapped and aims to structure the deal similarly to previous transactions like Remexian.
Q:What is the outlook for Germany's February sales and gross margins?
A:February sales in Germany reached $12 million with a 20% gross margin, the highest since acquiring Remexian. However, this performance is not expected to be a consistent benchmark due to factors like import permit delays. Gross margins are projected to stabilize between 20%-25% in Q3 and beyond, especially with Canadian biomass expected to arrive soon.
Q:What is the focus of organic store growth in Canada, and are there plans for M&A?
A:The company plans to open 20-30 organic stores in Canada this year, focusing primarily on Ontario but also targeting Alberta and Saskatchewan. M&A is also a priority, with plans to acquire existing stores rather than adding net new stores to the market.
Q:What is the expectation for brick-and-mortar gross margins given market slowdown?
A:Brick-and-mortar gross margins have reached 28% for five consecutive quarters. While further expansion may be limited, initiatives like white label products and ELITE memberships are expected to sustain or slightly improve margins. Competitive pressures and illicit market challenges may impact margins in some locations.
Q:What changes have been implemented in e-commerce platforms, and are they driving recovery?
A:The company has relaunched several e-commerce platforms, resulting in a 30%-50% increase in conversions and a 30% increase in orders. Sequential revenue growth was observed for the first time in three years, and the momentum is continuing into Q2.
Q:Will changes in Canada's medical cannabis reimbursement impact recreational sales?
A:Management does not expect changes in medical cannabis reimbursement to significantly impact recreational sales, as the medical and recreational markets are distinct.
Q:What is the outlook for Germany's cannabis market growth and availability?
A:Germany's cannabis market is growing rapidly, with annualized imports reaching 227 tonnes and over 1 million patients. More than 1 in 7 pharmacies now offer cannabis, and the market is expected to continue expanding.
Q:What are the reasons for the market slowdown in Canada, and how is the company addressing it?
A:The market slowdown in Canada is attributed to inflationary pressures, potential recession concerns, and competition from the illicit market. The company remains focused on its strategy and believes it will benefit disproportionately when the market recovers.
Q:How is the company driving growth in ELITE memberships?
A:The company is leveraging marketing, sales, advertising, and exclusive benefits to drive ELITE membership growth. Memberships are growing at 100% year-over-year, and the company expects to reach 320,000 members soon.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on how the U.K. market entry will be funded, using vague language about not being cash-strapped and taking a strategic approach. Additionally, they did not provide a clear benchmark for Germany's February sales performance, emphasizing variability due to external factors like import permit delays.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ATB Comark
CBD accessory
CBD business
CBD pilot
Canada ELITE
Canada calendar
Canada class
Canada segment
Care Council
Comark potential
Compassionate Care
High Tide
Mr Raj
Ontario store
Portugal
Raj President
Tide Inc
biomass Canada
change
confidence
contrast
conversation
drag
flow basis
import
label product
loyalty
majority
month Remexian
option
sale increase
sale period
sale province
segment gain
shipment
steam
tonne
valuation
year store
HITI Transcript
High Tide Inc. (HITI:CA) Q2 2026 Earnings Call Transcript
Neutral6-16
High Tide Inc. (HITI:CA) Q1 2026 Earnings Call Transcript
Positive3-18
The earnings call highlights strong financial performance, including record high revenue and free cash flow, improved margins, and strategic growth plans in Europe and the U.S. Despite some market slowdown concerns, management's optimistic guidance and strategic initiatives like store expansion and e-commerce improvements suggest a positive outlook. The Q&A section reveals some uncertainties, but overall, the sentiment is positive, with strategic partnerships and market expansion plans expected to drive growth. The lack of market cap information prevents further granularity, but the overall sentiment leans towards a positive stock price movement.
High Tide Inc. (HITI:CA) Q4 2025 Earnings Call Transcript
Unknown1-30
The earnings call revealed mixed insights: stable financials with strong EBITDA in Canada, but challenges like supply chain issues in Europe and reduced free cash flow. Positive growth strategies and membership expansion are offset by uncertainties in U.S. regulatory impacts and vague guidance on German market prospects. The Q&A session highlighted management's cautious approach to M&A and market expansion, which may temper investor enthusiasm. Overall, the balance of positive and negative factors suggests a neutral stock price movement.
High Tide Inc. (HITI:CA) Q3 2025 Earnings Call Transcript
Positive9-16
The earnings call highlights strong financial performance with record revenue and significant free cash flow growth. Membership growth and strategic expansion plans are promising. Despite some concerns about e-commerce and supply chain issues, management's optimism about U.S. market entry and margin improvements are positive. The Q&A reveals confidence in market share gains and strategic investments. Overall, strong financial metrics and growth plans outweigh the uncertainties, suggesting a positive stock price movement.
HITI Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
